Malignant Germ Cell–Like Tumors, Expressing Ki-1 Antigen (CD30), Are Revealed during in Vivo Differentiation of Partially Reprogrammed Human-Induced Pluripotent Stem Cells

The American Journal of Pathology, 05/02/2012

The oncogenicity of therapeutically valuable patient–specific induced pluripotent stem cells–derived cells should be scrupulously evaluated before they are used for any clinical applications.

Print Article Summary Cat 2 CME Report